IP Library Granted Patent US 11,084,844
Granted Patent B2
US 11,084,844 · App. 16/117,435 · Granted Aug 10, 2021

Modified nucleosides, analogs thereof and oligomeric compounds prepared therefrom

Inventors: Thazha P. Prakash (Carlsbad, CA); Punit P. Seth (Carlsbad, CA); Eric E. Swayze (Encinitas, CA)
Assignee: Ionis Pharmaceuticals, inc.
C07H21/00C07H19/067C07H19/10C07H19/167C07H19/20C07H21/02C12N15/113C12N15/1135C12N15/1137C12N2310/11C12N2310/14C12N2310/31C12N2310/315C12N2310/318C12N2310/321C12N2310/322C12N2310/3231C12N2310/345C12N2310/346C12N2320/30C12N2320/51
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,084,844
App. No.
16/117,435
Granted
Aug 10, 2021
Kind
B2
Abstract

The present invention provides modified nucleosides, analogs thereof and oligomeric compounds prepared therefrom. More particularly, the present invention provides modified nucleosides and analogs thereof that are useful for incorporation at the terminus of an oligomeric compound. Such oligomeric compounds can also be included in a double stranded composition. In some embodiments, the oligomeric compounds provided herein are expected to hybridize to a portion of a target RNA resulting in loss of normal function of the target RNA.

Claims (70)

1. An oligomeric compound comprising at the 5′-position a moiety having Formula IIc:

wherein:

Bx 1 is a heterocyclic base moiety;

T 1 is an optionally protected phosphorus moiety having the formula:

T 2 is an internucleoside linking group linking the compound of Formula IIc to the oligomeric compound;

A has one of the formulas:

R a and R c are each, independently, OH, SH, protected hydroxyl, protected thiol, C 1 -C 6 alkyl, substituted C 1 -C 6 alkyl, C 1 -C 6 alkoxy, substituted C 1 -C 6 alkoxy, protected amino or substituted amino;

R b is O or S;

Q 1 and Q 2 are each, independently, H, halogen, C 1 -C 6 alkyl, substituted C 1 -C 6 alkyl, C 1 -C 6 alkoxy, or substituted C 1 -C 6 alkoxy;

M 3 is OC(R 15 )(R 16 );

R 15 and R 16 are each, independently, H, halogen, C 1 -C 6 alkyl, substituted C 1 -C 6 alkyl, C 1 -C 6 alkoxy, substituted C 1 -C 6 alkoxy, C 2 -C 6 alkenyl, substituted C 2 -C 6 alkenyl, C 2 -C 6 alkynyl or substituted C 2 -C 6 alkynyl;

J 4 , J 5 , J 6 and J 7 are each, independently, H, halogen, C 1 -C 6 alkyl, substituted C 1 -C 6 alkyl, C 1 -C 6 alkoxy, substituted C 1 -C 6 alkoxy, C 2 -C 6 alkenyl, substituted C 2 -C 6 alkenyl, C 2 -C 6 alkynyl or substituted C 2 -C 6 alkynyl;

or J 4 forms a bridge with J 5 or J 7 wherein said bridge comprises from 1 to 3 linked biradical groups selected from O, S, NR 19 , C(R 20 )(R 21 ), C(R 20 )═C(R 21 ), C[═C(R 20 )(R 21 )] and C(═O) and the other two of J 5 , J 6 and J 7 are each, independently, H, halogen, C 1 -C 6 alkyl, substituted C 1 -C 6 alkyl, C 1 -C 6 alkoxy, substituted C 1 -C 6 alkoxy, C 2 -C 6 alkenyl, substituted C 2 -C 6 alkenyl, C 2 -C 6 alkynyl or substituted C 2 -C 6 alkynyl;

R 19 , R 20 and R 21 are each, independently, H, C 1 -C 6 alkyl, substituted C 1 -C 6 alkyl, C 1 -C 6 alkoxy, substituted C 1 -C 6 alkoxy, C 2 -C 6 alkenyl, substituted C 2 -C 6 alkenyl, C 2 -C 6 alkynyl or substituted C 2 -C 6 alkynyl;

G is H, OH, halogen or O—[C(R 8 )(R 9 )] n —[(C═O) m —X 1 ] i —Z;

R 8 and R 9 are each, independently, H, halogen, C 1 -C 6 alkyl or substituted C 1 -C 6 alkyl;

X 1 is O, S or N(E 1 );

Z is H, halogen, C 1 -C 6 alkyl, substituted C 1 -C 6 alkyl, C 2 -C 6 alkenyl, substituted C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, substituted C 2 -C 6 alkynyl or N(E 2 )(E 3 );

E 1 , E 2 and E 3 are each, independently, H, C 1 -C 6 alkyl or substituted C 1 -C 6 alkyl;

n is from 1 to about 6;

m is 0 or 1;

j is 0 or 1;

each substituted group comprises one or more optionally protected substituent groups independently selected from halogen, OJ 1 , N(J 1 )(J 2 ), ═NJ 1 , Sh 1 , N 3 , CN, OC(═X)J 1 , OC(═X)N(J 1 )(J 2 ) and C(═X)N(J 1 )(J 2 );

X is O, S or NJ 3 ; and

J 1 , J 2 and J 3 are each, independently, H or C 1 -C 6 alkyl.

2. The compound of claim 1 , wherein each of J 4 , J 5 , J 6 , J 7 , R 15 and R 16 is H.

3. The compound of claim 1 , wherein T 1 -A is

4. The compound of claim 1 , wherein exactly one of J 7 and G is F and the other of J 7 and G is H.

5. The compound of claim 1 , wherein G is OMe and J 7 is H.

6. The compound of claim 1 , wherein G is O(CH 2 ) 2 OCH 3 and J 7 is H.

7. The compound of claim 1 , wherein Q 1 and Q 2 are each, independently, H or C 1 -C 6 alkyl.

8. The compound of claim 1 , wherein Q 1 and Q 2 are each H.

9. The compound of claim 1 , wherein R a and R c are each, independently, OH, OCH 3 , OCH 2 CH 3 , or OCH(CH 3 ) 2 .

10. The compound of claim 9 , wherein R b is O.

11. An oligomeric compound comprising at the 5′-position a moiety having formula IIc:

wherein:

Bx is a heterocyclic base moiety;

T 1 is an optionally protected phosphorus moiety having the formula:

T 2 is an internucleoside linking group linking the compound of Formula IIc to the oligomeric compound;

A has one of the formulas:

R a and R c are each, independently, OH, SH, protected hydroxyl, protected thiol, C 1 -C 6 alkyl, substituted C 1 -C 6 alkyl, C 1 -C 6 alkoxy, substituted C 1 -C 6 alkoxy, protected amino or substituted amino;

R b is O or S;

Q 1 and Q 2 are each, independently, H, halogen, C 1 -C 6 alkyl, substituted C 1 -C 6 alkyl, C 1 -C 6 alkoxy, or substituted C 1 -C 6 alkoxy;

M 3 is C(R 15 )═C(R 17 );

R 15 and R 17 are each, independently, H, halogen, C 1 -C 6 alkyl, substituted C 1 -C 6 alkyl, C 1 -C 6 alkoxy, substituted C 1 -C 6 alkoxy, C 2 -C 6 alkenyl, substituted C 2 -C 6 alkenyl, C 2 -C 6 alkynyl or substituted C 2 -C 6 alkynyl;

J 4 , J 5 , J 6 and J 7 are each, independently, H, halogen, C 1 -C 6 alkyl, substituted C 1 -C 6 alkyl, C 1 -C 6 alkoxy, substituted C 1 -C 6 alkoxy, C 2 -C 6 alkenyl, substituted C 2 -C 6 alkenyl, C 2 -C 6 alkynyl or substituted C 2 -C 6 alkynyl;

or J 4 forms a bridge with J 5 or J 7 wherein said bridge comprises from 1 to 3 linked biradical groups selected from O, S, NR 19 , C(R 20 )(R 21 ), C(R 20 )═C(R 21 ), C[═C(R 20 )(R 21 )] and C(═O) and the other two of J 5 , J 6 and J 7 are each, independently, H, halogen, C 1 -C 6 alkyl, substituted C 1 -C 6 alkyl, C 1 -C 6 alkoxy, substituted C 1 -C 6 alkoxy, C 2 -C 6 alkenyl, substituted C 2 -C 6 alkenyl, C 2 -C 6 alkynyl or substituted C 2 -C 6 alkynyl;

each R 19 Rao and R 21 is, independently, H, C 1 -C 6 alkyl, substituted C 1 -C 6 alkyl, C 1 -C 6 alkoxy, substituted C 1 -C 6 alkoxy, C 2 -C 6 alkenyl, substituted C 2 -C 6 alkenyl, C 2 -C 6 alkynyl or substituted C 2 -C 6 alkynyl;

G is H, OH, halogen or O—[C(R 8 )(R 9 )] n —[(C═O) m —X 1 ] j —Z;

each R 8 and R 9 is, independently, H, halogen, C 1 -C 6 alkyl or substituted C 1 -C 6 alkyl;

X 1 is O, S or N(E 1 );

Z is H, halogen, C 1 -C 6 alkyl, substituted C 1 -C 6 alkyl, C 2 -C 6 alkenyl, substituted C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, substituted C 2 -C 6 alkynyl or N(E 2 )(E 3 );

E 1 , E 2 and E 3 are each, independently, H, C 1 -C 6 alkyl or substituted C 1 -C 6 alkyl;

n is from 1 to about 6;

m is 0 or 1;

j is 0 or 1;

each substituted group comprises one or more optionally protected substituent groups independently selected from halogen, OJ 1 , N(J 1 )(J 2 ), ═NJ 1 , SJ 1 , N 3 , CN, OC(═X)J 1 , OC(=X)N(J 1 )(J 2 ) and C(═X)N(J 1 )(J 2 );

X is O, S or NJ 3 ; and

J 1 , J 2 and J 3 are each, independently, H or C 1 -C 6 alkyl.

12. The compound of claim 11 , wherein each of J 4 , J 5 , J 6 , J 7 , R 15 and R 17 is H.

13. The compound of claim 11 , wherein each of J 4 , J 5 , J 6 , J 7 , R 15 and R 17 is H; exactly one of J 7 and G is H, and the other of J 7 and G is a sugar substituent group selected from halogen, hydroxyl, C 1 -C 6 alkyl, C 1 -C 6 alkoxy, and substituted C 1 -C 6 alkoxy; wherein each substituted group comprises one or more optionally protected substituent groups independently selected from halogen, OJ 1 , N(J 1 )(J 2 ), ═NJ 1 , SJ 1 , N 3 , CN, OC(═X)J 1 , OC(═X)N(J 1 )(J 2 ) and C(═X)N(J 1 )(J 2 );

X is O, S or NJ 3 ; and

J 1 , J 2 and J 3 are each, independently, H or C 1 -C 6 alkyl.

14. The compound of claim 13 , wherein exactly one of J 7 and G is H and the other is F.

15. The compound of claim 13 , wherein exactly one of J 7 and G is H and the other is OMe or O(CH 2 ) 2 OCH 3 .

16. The compound of claim 11 , wherein T 1 -A is

17. The compound of claim 11 , wherein Q 1 and Q 2 are each, independently, H or C 1 -C 6 alkyl.

18. The compound of claim 11 , wherein Q 1 and Q 2 are each H.

19. The compound of claim 11 , wherein R a and R c are each, independently, OH, OCH 3 , OCH 2 CH 3 , or OCH(CH 3 ) 2 .

20. The compound of claim 19 , wherein R b is O.

Continuity (7)
Continuation 15073386 · Mar 17, 2016
Continuation 14627960 · Feb 20, 2015
Division 13642827
Provisional Application 61409684 · Nov 3, 2010
Provisional Application 61393100 · Oct 14, 2010
Provisional Application 61328990 · Apr 28, 2010
Related Publication 20180371005A1 · Dec 27, 2018
Cited By (4)
US 12,234,290 US 12,351,637 US 12,364,769 US 12,365,704